Sa1289 Analysis of Clinical and Serological Associations, and the Clinical Consequences of the Development of Human Anti-Chimeric Antibodies (HACAs), and Low Serum Infliximab (IFX) Levels in Inflammatory Bowel Disease (IBD)

✍ Scribed by Sundip S. Karsan; Erica R. Cohen; Stephan R. Targan; Andrew Ippoliti; David Q. Shih; Eric A. Vasiliauskas; Marla Dubinsky; Dror Berel; Dermot P. McGovern

• Book ID: 118519615
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 95 KB
• Volume: 142
• Category: Article
• ISSN: 0016-5085
• DOI: 10.1016/s0016-5085(12)60996-2